Evidence map›Paper›PMID 42619655›Full record

ArticleDalton transactions (Cambridge, England : 2003)2026

Copper(I) photosensitisers for antimicrobial photodynamic therapy: from solution studies to silica-immobilised composite materials.

Alexander Dukalski, Çağrı Özsan, Florian Doettinger, Anastasiia Riabchunova, Lukas Geciauskas, Sofia Fulgencio, Katherine S L Keating, Stefanie Tschierlei, Michael Karnahl, Angelo Frei

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Dalton transactions (Cambridge, England : 2003), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alexander DukalskiDepartment of Energy Conversion, Institute of Physical and Theoretical Chemistry, Technische Universität Braunschweig, Rebenring 31, 38106 Braunschweig, Germany. michael.karnahl@tu-bs.de.ORCID http://orcid.org/0009-0005-5172-7124
Çağrı ÖzsanDepartment of Chemistry, Biochemistry & Pharmaceutical Sciences, University of Bern, Bern, Switzerland.
Florian DoettingerDepartment of Energy Conversion, Institute of Physical and Theoretical Chemistry, Technische Universität Braunschweig, Rebenring 31, 38106 Braunschweig, Germany. michael.karnahl@tu-bs.de.ORCID http://orcid.org/0000-0003-2867-5184
Anastasiia RiabchunovaDepartment of Energy Conversion, Institute of Physical and Theoretical Chemistry, Technische Universität Braunschweig, Rebenring 31, 38106 Braunschweig, Germany. michael.karnahl@tu-bs.de.ORCID http://orcid.org/0000-0001-9373-799X
Lukas GeciauskasDepartment of Chemistry, University of York, York, UK. angelo.frei@york.ac.uk.ORCID http://orcid.org/0000-0003-4443-0144
Sofia FulgencioDepartment of Chemistry, Biochemistry & Pharmaceutical Sciences, University of Bern, Bern, Switzerland.
Katherine S L KeatingDepartment of Chemistry, University of York, York, UK. angelo.frei@york.ac.uk.
Stefanie TschierleiDepartment of Energy Conversion, Institute of Physical and Theoretical Chemistry, Technische Universität Braunschweig, Rebenring 31, 38106 Braunschweig, Germany. michael.karnahl@tu-bs.de.ORCID http://orcid.org/0000-0001-9441-7904
Michael KarnahlDepartment of Energy Conversion, Institute of Physical and Theoretical Chemistry, Technische Universität Braunschweig, Rebenring 31, 38106 Braunschweig, Germany. michael.karnahl@tu-bs.de.ORCID http://orcid.org/0000-0002-6755-0002
Angelo FreiDepartment of Chemistry, Biochemistry & Pharmaceutical Sciences, University of Bern, Bern, Switzerland.ORCID http://orcid.org/0000-0001-6169-2491

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial photodynamic therapy (aPDT) is an emerging approach to treat localised drug-resistant infections by generating reactive oxygen species with spatial and temporal control. Herein, we report the systematic assessment of six heteroleptic Cu(I) diimine-diphosphine photosensitisers of the type [Cu(N^N)(P^P)]

Identifiers

PMID42619655
PMCPMC13491392

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.